Multipurpose prevention technologies (MPTs) are defined and described in this fact sheet, which also explains how these technologies could save lives by combining family planning and prevention of sexually transmitted infections, including HIV.
A webpage provides a description of the FEM-PrEP trial of pre-exposure prophylaxis for HIV prevention among women and links to fact sheets and publications describing the results of the trial and related research.
FHI 360 and Sonke Gender Justice conducted a gender analysis for microbicide introduction in South Africa. The process included a desk review, interviews with key stakeholders, and an interpretation meeting to identify gender norms and inequalities that increase women’s HIV risk and could inhibit women’s access and adherence to microbicides in the future. This brief outlines 11 strategies that could be part of a microbicide introduction program to overcome these gender-related barriers.
FHI 360 and Sonke Gender Justice conducted a gender analysis in South Africa to identify gender-related barriers and opportunities to women’s microbicide access and use and to make recommendations for addressing those barriers. This pocket card, created with input from the South African National AIDS Council (SANAC) Men’s and Women’s sectors, is designed to build support for a gender-integrated microbicides rollout among community members and policy makers.
Based on findings from a gender analysis in Kenya, these advocacy tools can be used to raise awareness of key gender issues that need to be addressed in planning for microbicide introduction in Kenya. The guide includes: (1) a summary of gender issues that will affect women’s microbicide access and use; (2) guidance for policymakers and program designers on developing a gender-transformative microbicide introduction program; and (3) three case studies that nongovernmental organizations and other advocates in the community can use to generate discussion about microbicides.
This manual provides guidance for conducting a gender analysis in a country preparing to introduce microbicides. A gender analysis can strengthen the effectiveness of health and development programming by identifying gender inequalities that may affect program outcomes and potential ways to address those inequalities.The manual outlines the steps to conducting a gender analysis for microbicide introduction, shares lessons learned from pilot testing in Kenya and South Africa, and provides tools and resources for conducting a gender analysis for microbicide introduction.
This webpage describes a follow-up study to the CAPRISA 004 tenofovir gel trial, CAPRISA 008, which assessed the feasibility and effectiveness of distributing tenofovir gel through family planning clinics in communities where the CAPRISA 004 trial took place.